Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Drugs of Abuse pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Drugs of Abuse Tests are used for the detection of illegal and/or prescribed substances in the patient samples including urine, blood, saliva, or sweat.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Drugs of Abuse under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Drugs of Abuse and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Drugs of Abuse under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Drugs of Abuse Overview
  • Products under Development
    • Drugs of Abuse - Pipeline Products by Stage of Development
      • Table Figure 1: Drugs of Abuse - Pipeline Products by Stage of Development
      • Table Drugs of Abuse - Pipeline Products by Stage of Development
    • Drugs of Abuse - Pipeline Products by Territory
      • Table Figure 2: Drugs of Abuse - Pipeline Products by Territory
      • Table Drugs of Abuse - Pipeline Products by Territory
    • Drugs of Abuse - Pipeline Products by Regulatory Path
      • Table Figure 3: Drugs of Abuse - Pipeline Products by Regulatory Path
      • Table Drugs of Abuse - Pipeline Products by Regulatory Path
    • Drugs of Abuse - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Drugs of Abuse - Pipeline Products by Estimated Approval Date
      • Table Drugs of Abuse - Pipeline Products by Estimated Approval Date
  • Drugs of Abuse - Pipeline Products under Development by Companies
    • Drugs of Abuse Companies - Pipeline Products by Stage of Development
      • Table Drugs of Abuse Companies - Pipeline Products by Stage of Development
    • Drugs of Abuse – Companies Pipeline Products by Stage of Development
      • Table Drugs of Abuse – Companies Pipeline Products by Stage of Development
  • Drugs of Abuse Companies and Product Overview
    • Accelerate Diagnostics Inc Company Overview
      • Accelerate Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Accelerate Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Accelerate Pheno System - Intra-Abdominal Infections Assay - Product Status
        • Table Accelerate Pheno System - Intra-Abdominal Infections Assay - Product Description
        • Table Accelerate Pheno System - Urinary Tract Infections Assay - Product Status
        • Table Accelerate Pheno System - Urinary Tract Infections Assay - Product Description
    • Adaltis Srl Company Overview
      • Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table CLIAgen Steroid Assay - Product Status
        • Table CLIAgen Steroid Assay - Product Description
    • Banyan Biomarkers Inc Company Overview
      • Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Alcoholism - Product Status
        • Table Diagnostic Assay - Alcoholism - Product Description
    • Behavioral Diagnostics Inc Company Overview
      • Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epigenetic Test - Alcohol Abstinence - Product Status
        • Table Epigenetic Test - Alcohol Abstinence - Product Description
    • BioMark Technologies Inc Company Overview
      • BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ABA-SUBSTANCE - Product Status
        • Table ABA-SUBSTANCE - Product Description
    • Ceres Nanosciences Inc Company Overview
      • Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotrap Fentanyl Assay - Product Status
        • Table Nanotrap Fentanyl Assay - Product Description
    • genedrive plc Company Overview
      • genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genedrive - OPRM1 Assay - Product Status
        • Table Genedrive - OPRM1 Assay - Product Description
    • Horiba Ltd Company Overview
      • Horiba Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Horiba Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pentra C200 Analyzer - DAU Assay - Product Status
        • Table Pentra C200 Analyzer - DAU Assay - Product Description
    • OpalGenix Inc Company Overview
      • OpalGenix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OpalGenix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GPS-Opioid - Product Status
        • Table GPS-Opioid - Product Description
    • Randox Laboratories Ltd Company Overview
      • Randox Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Randox Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rx Daytona - Oxycodone Assay - Product Status
        • Table Rx Daytona - Oxycodone Assay - Product Description
        • Table Rx Daytona - Propoxyphene Assay - Product Status
        • Table Rx Daytona - Propoxyphene Assay - Product Description
        • Table RX Imola Cotinine Test - Product Status
        • Table RX Imola Cotinine Test - Product Description
        • Table RX Imola Oxycodone Test - Product Status
        • Table RX Imola Oxycodone Test - Product Description
        • Table RX Imola Propoxyphene Test - Product Status
        • Table RX Imola Propoxyphene Test - Product Description
    • Roche Diagnostics International Ltd Company Overview
      • Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chromate (SV) Assay - Product Status
        • Table Chromate (SV) Assay - Product Description
        • Table Oxidant (SV) Assay - Product Status
        • Table Oxidant (SV) Assay - Product Description
        • Table pH Assay - Product Status
        • Table pH Assay - Product Description
        • Table Specific Gravity Assay - Product Status
        • Table Specific Gravity Assay - Product Description
        • Table THC Oral Fluid Assay - Product Status
        • Table THC Oral Fluid Assay - Product Description
    • SDI Biomed, Inc. Company Overview
      • SDI Biomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table SDI Biomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table SDI CA 480 - Drugs Of Abuse Assay - Product Status
        • Table SDI CA 480 - Drugs Of Abuse Assay - Product Description
    • SensoDXII LLC Company Overview
      • SensoDXII LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SensoDXII LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SensoDx Drug Screen - Product Status
        • Table SensoDx Drug Screen - Product Description
    • Siemens Healthcare Diagnostics Inc Company Overview
      • Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dimension RxL Max Test - Meperidine - Product Status
        • Table Dimension RxL Max Test - Meperidine - Product Description
    • Siemens Healthineers AG Company Overview
      • Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dimension RxL Max Test - Oxycodone - Product Status
        • Table Dimension RxL Max Test - Oxycodone - Product Description
        • Table Dimension RxL Max Test - Tramadol - Product Status
        • Table Dimension RxL Max Test - Tramadol - Product Description
        • Table Viva-E Drug Testing System - Syva Emit DAT 6 Acetyl Morphine Assay - Product Status
        • Table Viva-E Drug Testing System - Syva Emit DAT 6 Acetyl Morphine Assay - Product Description
        • Table Viva-Jr Drug Testing System - Syva Emit DAT 6 Acetyl Morphine Assay - Product Status
        • Table Viva-Jr Drug Testing System - Syva Emit DAT 6 Acetyl Morphine Assay - Product Description
    • Thermo Fisher Scientific Inc Company Overview
      • Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cascadion SM Clinical Analyzer - Drugs Of Abuse Assay - Product Status
        • Table Cascadion SM Clinical Analyzer - Drugs Of Abuse Assay - Product Description
    • University of California San Francisco Company Overview
      • University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Steroid Detection Assay - Product Status
        • Table Steroid Detection Assay - Product Description
    • ZORA Biosciences Oy Company Overview
      • ZORA Biosciences Oy Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZORA Biosciences Oy Pipeline Products & Ongoing Clinical Trials Overview
        • Table Statin Intolerance Risk Test - Product Status
        • Table Statin Intolerance Risk Test - Product Description
  • Drugs of Abuse- Recent Developments
    • Sep 14, 2022: Horiba announces Review of First Half of 2022
    • Sep 06, 2022: Labcorp to Speak at the Baird 2022 Global Healthcare Conference
    • Aug 24, 2022: New line of electrochemistry bench meters simplify pH, conductivity and dissolved oxygen measurement
    • Aug 12, 2022: Horiba announce Summary of Consolidated Financial Statements for the Six Months Ended June 30, 2022
    • Aug 09, 2022: OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year
    • Jul 28, 2022: Labcorp Announces 2022 Second Quarter Results
    • May 17, 2022: Labcorp to Speak at the UBS 2022 Global Healthcare Conference
    • May 10, 2022: OraSure Reports 1Q22 Record Revenue of $67.7 Million +16% Year-Over-Year With 21% Growth in Non-COVID Revenue
    • May 04, 2022: Labcorp to Webcast Its Annual Meeting of Shareholders
    • Apr 11, 2022: Thermo Fisher Scientific to Host Investor Day
    • Mar 22, 2022: OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role
    • Feb 23, 2022: Orasure Technologies Reports 4q21 Revenue of $63.6 Million; Inteliswab® Production Scales Up
    • Feb 14, 2022: Horiba announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2021
    • Feb 02, 2022: Salimetrics expands laboratory CLIA Certification for Saliva Testing
    • Jan 04, 2022: Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference
    • Dec 31, 2021: Improve Medical Instruments Announces on the Resignation of the Secretary of the Board of Directors and the Appointment of the Secretary of the Board of Directors
    • Nov 12, 2021: Psychemedics Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021
    • Nov 11, 2021: Horiba Announces Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2021
    • Nov 03, 2021: OraSure Technologies Reports 3Q21 Revenue of $53.9 Million
    • Nov 02, 2021: Labcorp to Speak at Credit Suisse 30th Annual Healthcare Conference
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings